Skip to main content
Premium Trial:

Request an Annual Quote

BG Medicine, Mitsubishi Pharma Partner on Biomarker Discovery for Muscle Toxicity

NEW YORK, March 28 (GenomeWeb News) - BG Medicine said today that it has signed a collaborative research agreement with Mitsubishi Pharma of Osaka, Japan, to discover biomarkers associated with muscle toxicity in lipid-lowering compounds.


BG Medicine said it will use proteomics, metabolomics, and computational analyses to study the molecular effects of selected lipid-lowering agents on skeletal muscle and to identify specific plasma biomarkers of these effects.


Mitsubishi Pharma will contribute transcript, clinical chemistry, and histopathology data to the project.


BG Medicine said that it will jointly own "certain rights" to the project data and biomarkers with Mitsubishi Pharma, but additional terms of the agreement were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.